Aethlon director forfeits shares for tax withholding

Aethlon Medical director Chetan Shah reported a tax-related share forfeiture tied to equity compensation.

Rhea-AI Filing Summary

Aethlon Medical director Chetan Shah reported a tax-related share forfeiture tied to equity compensation. On conversion of 268 vested restricted stock units into common stock, he forfeited 178 shares at $2.19 per share to cover tax withholdings, based on the market price at the time.

Following this non-market transaction, Shah directly holds 1,463 shares of Aethlon Medical common stock. The disposition reflects routine tax settlement rather than an open-market sale or purchase decision.

Insider Trade Summary

Exercise Price or Tax Liability: 178 shares

Exercise Price or Tax Liability 1 txn

Insider Shah Chetan

Role Director

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	178	$2.19	$389.82

Holdings After Transaction: Common Stock — 1,463 shares (Direct)

Footnotes (1)

1. F1. The Reporting Person forfeited 178 shares of common stock upon conversion of an aggregate 268 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 25, 2025.

Key Figures

Shares forfeited for taxes: 178 shares Market price used for withholding: $2.19 per share Shares held after transaction: 1,463 shares +2 more

5 metrics

Shares forfeited for taxes 178 shares Tax-withholding disposition on RSU conversion at $2.19 per share

Market price used for withholding $2.19 per share Price at time of forfeiture for Aethlon common stock

Shares held after transaction 1,463 shares Chetan Shah’s direct Aethlon common stock holdings post-transaction

RSUs converted 268 units Vested restricted stock units converting into Aethlon common stock

Transaction date March 31, 2026 Date of tax-withholding disposition reported on Form 4

Key Terms

restricted stock units, tax withholdings, Form 4, forfeited

4 terms

restricted stock units financial

"conversion of an aggregate 268 vested and outstanding restricted stock units into shares of common stock"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholdings financial

"to cover tax withholdings, using the market price of the issuer's common stock"

Form 4 regulatory

"grant reported in Table I of the Form 4 filed by the Reporting Person"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

forfeited financial

"The Reporting Person forfeited 178 shares of common stock upon conversion"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Aethlon Medical (AEMD) director Chetan Shah report in this Form 4?

Chetan Shah reported forfeiting 178 Aethlon Medical shares to satisfy tax withholdings on vested restricted stock units. The transaction arose when 268 RSUs converted into common stock, and shares were withheld using the market price at the time of forfeiture.

Was Chetan Shah’s Aethlon Medical (AEMD) Form 4 a market sale of shares?

No, the Form 4 shows a tax-withholding disposition, not an open-market sale. 178 shares were forfeited automatically to cover tax obligations when 268 vested restricted stock units converted into Aethlon Medical common stock for the director.

How many Aethlon Medical (AEMD) shares did Chetan Shah forfeit for taxes?

He forfeited 178 shares of Aethlon Medical common stock. The shares were valued at $2.19 each, using the issuer’s market price at the time of forfeiture, and were surrendered solely to satisfy tax withholding requirements on his equity award.

How many Aethlon Medical (AEMD) shares does Chetan Shah hold after this Form 4 transaction?

After the tax-withholding forfeiture, Chetan Shah directly holds 1,463 shares of Aethlon Medical common stock. This figure reflects his position following conversion of 268 vested restricted stock units and the related disposition of 178 shares for tax obligations.

What triggered the tax withholding reported by Chetan Shah in Aethlon Medical’s Form 4?

The tax withholding was triggered when 268 vested and outstanding restricted stock units converted into Aethlon Medical common stock. To cover the resulting tax liability, 178 shares were forfeited, using the company’s market price at the time to determine the withholding amount.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/01/2026 - 07:27 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shah Chetan

(Last) (First) (Middle)

11555 SORRENTO VALLEY ROAD

SUITE 203

(Street)

SAN DIEGO CALIFORNIA 92121

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AETHLON MEDICAL INC [ AEMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/31/2026		F		178(1)	D	$2.19	1,463	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Reporting Person forfeited 178 shares of common stock upon conversion of an aggregate 268 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 25, 2025.

	/s/ Chetan Shah by: James B. Frakes, Attorney-in-fact	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)